Holen Sie sich die Stockscreener-App
6.34
10.07%
-0.71
Handel nachbörslich:
6.31
-0.03
-0.47%
Schlusskurs vom Vortag:
$7.05
Offen:
$7.03
24-Stunden-Volumen:
79,522
Relative Volume:
0.24
Marktkapitalisierung:
$19.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-5.4188
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+11.82%
1M Leistung:
+1,815%
6M Leistung:
+999.93%
1J Leistung:
+574.47%
1-Tages-Spanne:
$6.20
$7.03
1-Wochen-Bereich:
$5.52
$7.6996
52-Wochen-Spanne:
$0.257
$7.6996
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
6.34 | 23.21M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
Real time social sentiment graph for Passage Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser
Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsTrend Reversal Probability Forecast Update - Newser
Historical volatility pattern of Passage Bio Inc. visualizedFree Oversold Recovery Opportunity Stocks - Newser
What analysts say about Passage Bio Inc. stock outlookMonthly Long-Term Market Recap and Summary - Newser
Why Passage Bio Inc. stock attracts strong analyst attentionAI Entry Timing Prediction for Swing Traders - Newser
How strong is Passage Bio Inc. company’s balance sheetRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
What machine learning models say about Passage Bio Inc.Forecasting Stock Moves with AI Insights - Newser
What moving averages say about Passage Bio Inc. Weekly Breakout Forecast with Entry Zones - Newser
What machine learning models say about Passage Bio Inc. Accurate Forecast System with AI Support - Newser
Does Passage Bio Inc. stock perform well during market downturnsExplosive trading opportunities - jammulinksnews.com
What is the dividend policy of Passage Bio Inc. stockBreakout stock performance - jammulinksnews.com
What are Passage Bio Inc. company’s key revenue driversBuild a diversified portfolio for risk management - jammulinksnews.com
What are the latest earnings results for Passage Bio Inc.Superior trading gains - jammulinksnews.com
What are analysts’ price targets for Passage Bio Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - jammulinksnews.com
Is Passage Bio Inc. Stock a Good Fit for Conservative InvestorsRisk Controlled Trading Ideas - Newser
Passage Bio Skyrockets 31.04%—Is Institutional Buying the Catalyst for a Biotech Breakout? - AInvest
What analysts say about Passage Bio Inc. stockFree Trading Psychology Coaching - Autocar Professional
Passage Bio Soars 12.39% on Institutional Buying Spree - AInvest
What drives Passage Bio Inc. stock priceAccelerated financial growth - PrintWeekIndia
Passage Bio Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
Will Passage Bio Inc. stock benefit from interest rate changesAccelerated earnings growth - jammulinksnews.com
What makes Passage Bio Inc. stock price move sharplyStable Growth Stock Picks - Newser
Lynx1 capital buys Passage Bio (PASG) shares worth $733,825 - Investing.com
Is Passage Bio Inc. a good long term investmentFree Stock Movement Tracking - jammulinksnews.com
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Passage Bio Inc-Aktie (PASG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
10.28%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):